Venus Remedies Ltd Gains 0.23%: 3 Key Factors Driving the Weekly Move

23 March 2026: Lower Circuit Triggered Amid Sector Weakness

Venus Remedies Ltd opened the week on a weak note, hitting its lower circuit limit with a sharp intraday decline of 5.0%, closing at Rs.823.75. This 4.99% drop was more severe than the Sensex’s 3.13% fall, signalling intense selling pressure specific to the stock. The Pharmaceuticals & Biotechnology sector also declined by 3.07%, indicating broader sectoral challenges.

Trading volumes were subdued at 2,975 shares, with delivery volumes contracting by 27.5% compared to the five-day average, suggesting waning investor participation amid panic selling. Despite this short-term weakness, the stock remained above its longer-term moving averages, reflecting some underlying resilience. The Mojo Score of 74.0 and a recent upgrade to a Buy grade provided a counterbalance to the immediate technical distress.

24 March 2026: Sharp Rebound to Upper Circuit on Renewed Buying

The following day, Venus Remedies Ltd staged a strong recovery, surging 5.0% to hit the upper circuit at Rs.864.90. This rally outpaced the sector’s 1.32% gain and the Sensex’s 1.95% advance, highlighting renewed investor enthusiasm. The stock traded actively with volumes rising to 3,266 shares and turnover reaching ₹3.35 crore.

Investor participation improved markedly, with delivery volumes increasing by 23.63%, signalling genuine accumulation rather than speculative trading. The weighted average price suggested cautious early buying that accelerated into the close. Technically, the stock remained above all key moving averages except the 5-day, indicating a short-term consolidation before the breakout.

25 March 2026: Continued Momentum with Another Upper Circuit

Venus Remedies Ltd extended its gains on 25 March, hitting the upper circuit again with a 4.3% rise to close at Rs.881.65. The stock outperformed the Pharmaceuticals & Biotechnology sector’s 1.87% gain and the Sensex’s 1.98% advance, underscoring strong buying conviction. The intraday high reached Rs.909.55, the week’s peak price.

Trading volumes remained robust at 3,574 shares, with turnover of ₹2.79 crore. Despite the strong price gains, delivery volumes declined by 18.15%, indicating some short-term trading activity alongside sustained demand. Technically, the stock traded above all major moving averages, signalling a strong bullish trend across multiple timeframes.

With a market capitalisation of ₹1,209 crore and a Mojo Score of 74.0, the stock’s fundamentals continue to support the positive price action. The proximity to its 52-week high of Rs.944.75 suggests that investors are closely watching for a potential breakout beyond this resistance level.

27 March 2026: Week Ends with Mild Correction

After two days of strong gains, Venus Remedies Ltd closed the week on a softer note, falling 1.43% to Rs.869.05. This decline came amid a broader market pullback, with the Sensex dropping 2.11%. The stock’s volume contracted sharply to 1,592 shares, reflecting reduced trading interest.

Despite the day’s loss, the stock ended the week slightly higher by 0.23%, outperforming the Sensex’s 1.46% weekly decline. The price action suggests some short-term profit-taking following the recent rally, but the stock remains above key moving averages, maintaining its medium-term bullish technical posture.

Key Takeaways from the Week

Volatility Amid Sectoral Pressure: The week began with a sharp decline and lower circuit hit, reflecting sector-wide weakness and panic selling. However, the stock’s ability to rebound strongly on consecutive days highlights resilience and renewed investor interest.

Strong Buying Momentum: Upper circuit hits on 24 and 25 March demonstrate robust demand and positive technical momentum. Rising delivery volumes on 24 March confirm genuine accumulation, although the dip in delivery volumes on 25 March suggests some short-term trading activity.

Technical Strength Maintained: Venus Remedies consistently traded above its 20-day, 50-day, 100-day, and 200-day moving averages throughout the week, signalling a sustained medium-term uptrend despite short-term fluctuations.

Market Capitalisation and Mojo Grade: With a micro-cap valuation around ₹1,200 crore and a Mojo Score of 74.0 rated as Buy, the stock’s fundamentals remain supportive amid the volatile price action.

Outperformance vs Sensex: Despite daily swings, Venus Remedies outperformed the Sensex’s 1.46% weekly decline by closing the week marginally higher, underscoring relative strength in a challenging market environment.

Conclusion

Venus Remedies Ltd’s week was marked by significant volatility, with sharp declines followed by strong rebounds culminating in two upper circuit hits. The stock’s ability to recover from panic selling and maintain technical strength above key moving averages reflects underlying resilience. While delivery volume trends indicate a mix of long-term accumulation and short-term trading, the upgraded Mojo Grade and micro-cap market capitalisation support a positive fundamental outlook.

Investors should monitor the stock’s ability to sustain momentum near its 52-week high and watch for sectoral developments that could influence sentiment. The week’s price action highlights the importance of balancing short-term volatility with medium-term technical and fundamental indicators when assessing Venus Remedies Ltd.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today